Dr. Trey Dobson: New oral treatments for Covid-19 are on the horizon

This commentary is by Trey Dobson, M.D., chief medical officer of Southwestern Vermont Medical Center in Bennington.  Patients with Covid-19 deemed to be at high risk for severe disease are currently eligible for intravenous monoclonal antibody treatments provided at certain health care systems, typically in hospitals. These medications are administered over a period of about an hour in an infusion center staffed by nurses and doctors. When given early in the disease, they reduce